Open Beta
MetriLume

US marketsBBNX

SEC-sourced researchBeta

BBNX

Beta Bionics, Inc.

Company comparison ↗

Data passport

CIK
0001674632
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 65,124,000.0000 USD; December 2025: 100,251,000.0000 USD100.3M USD0 USD0December 2024December 2025
BBNX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202465,124,000.0000Feb 24, 2026
December 2025100,251,000.0000Feb 24, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025100,251,000.0000-73,200,000.0000-50,925,000.0000328,743,000.000041,133,000.0000Feb 24, 2026
December 202465,124,000.0000-54,756,000.0000-48,273,000.0000149,645,000.000073,632,000.0000Feb 24, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$100.25MDecember 2025Feb 24, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$65.12MDecember 2024Feb 24, 202610-K
Net incomeNetIncomeLoss-$73.2MDecember 2025Feb 24, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$50.93MDecember 2025Feb 24, 202610-K
Total assetsAssets$328.74MDecember 2025Feb 24, 202610-K
Total liabilitiesLiabilities$41.13MDecember 2025Feb 24, 202610-K

New filings

Explore methodology ↗